Selected research
Market Structure
Global CRISPR-Cas9 Gene Editing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global CRISPR-Cas9 Gene Editing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for CRISPR-Cas9 Gene Editing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of CRISPR-Cas9 Gene Editing Service include AMSBIO, GenScript, Merck, Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, DefiniGEN, Synthego and Biocytogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global CRISPR-Cas9 Gene Editing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of CRISPR-Cas9 Gene Editing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents CRISPR-Cas9 Gene Editing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the CRISPR-Cas9 Gene Editing Service market size, projected growth trends, production technologies, key applications, and end-use industries.
CRISPR-Cas9 Gene Editing Service Segment by Company
AMSBIO
GenScript
Merck
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
DefiniGEN
Synthego
Biocytogen
Caribou
Horizon Discovery Ltd.
EdiGene, Inc.
DetaiBio
CRISPR-Cas9 Gene Editing Service Segment by Type
Knock-in Gene Editing Service
Knock-out Gene Editing Service
Other
CRISPR-Cas9 Gene Editing Service Segment by Application
Cell Line Construction
Animal Models
Bioagriculture
Other
CRISPR-Cas9 Gene Editing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRISPR-Cas9 Gene Editing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRISPR-Cas9 Gene Editing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRISPR-Cas9 Gene Editing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of CRISPR-Cas9 Gene Editing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CRISPR-Cas9 Gene Editing Service industry.
Chapter 3: Detailed analysis of CRISPR-Cas9 Gene Editing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CRISPR-Cas9 Gene Editing Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Knock-in Gene Editing Service
- Knock-out Gene Editing Service
- Other
Applications
- Cell Line Construction
- Animal Models
- Bioagriculture
- Other
Companies covered
- AMSBIO
- GenScript
- Merck
- Editas Medicine
- Intellia Therapeutics
- CRISPR Therapeutics
- DefiniGEN
- Synthego
- Biocytogen
- Caribou
- Horizon Discovery Ltd.
- EdiGene, Inc.
- DetaiBio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global CRISPR-Cas9 Gene Editing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Knock-in Gene Editing Service
- 1.2.3 Knock-out Gene Editing Service
- 1.2.4 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global CRISPR-Cas9 Gene Editing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Cell Line Construction
- 1.3.3 Animal Models
- 1.3.4 Bioagriculture
- 1.3.5 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global CRISPR-Cas9 Gene Editing Service Growth Trends by Region
- 1.5.1 Global CRISPR-Cas9 Gene Editing Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 CRISPR-Cas9 Gene Editing Service Market Size by Region (2021-2026)
- 1.5.3 CRISPR-Cas9 Gene Editing Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global CRISPR-Cas9 Gene Editing Service Market Dynamics
- 2.1 CRISPR-Cas9 Gene Editing Service Industry Trends
- 2.2 CRISPR-Cas9 Gene Editing Service Industry Drivers
- 2.3 CRISPR-Cas9 Gene Editing Service Industry Opportunities and Challenges
- 2.4 CRISPR-Cas9 Gene Editing Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global CRISPR-Cas9 Gene Editing Service Revenue by Company (2021-2026)
- 3.2 Global CRISPR-Cas9 Gene Editing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global CRISPR-Cas9 Gene Editing Service Key Company Head office and Area Served
- 3.4 Global CRISPR-Cas9 Gene Editing Service Company, Product Type & Application
- 3.5 Global CRISPR-Cas9 Gene Editing Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global CRISPR-Cas9 Gene Editing Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 CRISPR-Cas9 Gene Editing Service Players Market Share by Revenue in 2025
- 3.6.3 2025 CRISPR-Cas9 Gene Editing Service Tier 1, Tier 2, and Tier 3
4 CRISPR-Cas9 Gene Editing Service Market by Type
- 4.1 Global CRISPR-Cas9 Gene Editing Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global CRISPR-Cas9 Gene Editing Service Market Size by Type (2021-2032)
- 4.3 Global CRISPR-Cas9 Gene Editing Service Market Size Share by Type (2021-2032)
5 CRISPR-Cas9 Gene Editing Service Market by Application
- 5.1 Global CRISPR-Cas9 Gene Editing Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global CRISPR-Cas9 Gene Editing Service Market Size by Application (2021-2032)
- 5.3 Global CRISPR-Cas9 Gene Editing Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 AMSBIO
- 6.1.1 AMSBIO Company Information
- 6.1.2 AMSBIO Business Overview
- 6.1.3 AMSBIO CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 AMSBIO CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.1.5 AMSBIO Recent Developments
- 6.2 GenScript
- 6.2.1 GenScript Company Information
- 6.2.2 GenScript Business Overview
- 6.2.3 GenScript CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 GenScript CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.2.5 GenScript Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Merck CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Editas Medicine
- 6.4.1 Editas Medicine Company Information
- 6.4.2 Editas Medicine Business Overview
- 6.4.3 Editas Medicine CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Editas Medicine CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.4.5 Editas Medicine Recent Developments
- 6.5 Intellia Therapeutics
- 6.5.1 Intellia Therapeutics Company Information
- 6.5.2 Intellia Therapeutics Business Overview
- 6.5.3 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.5.5 Intellia Therapeutics Recent Developments
- 6.6 CRISPR Therapeutics
- 6.6.1 CRISPR Therapeutics Company Information
- 6.6.2 CRISPR Therapeutics Business Overview
- 6.6.3 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.6.5 CRISPR Therapeutics Recent Developments
- 6.7 DefiniGEN
- 6.7.1 DefiniGEN Company Information
- 6.7.2 DefiniGEN Business Overview
- 6.7.3 DefiniGEN CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 DefiniGEN CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.7.5 DefiniGEN Recent Developments
- 6.8 Synthego
- 6.8.1 Synthego Company Information
- 6.8.2 Synthego Business Overview
- 6.8.3 Synthego CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Synthego CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.8.5 Synthego Recent Developments
- 6.9 Biocytogen
- 6.9.1 Biocytogen Company Information
- 6.9.2 Biocytogen Business Overview
- 6.9.3 Biocytogen CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Biocytogen CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.9.5 Biocytogen Recent Developments
- 6.10 Caribou
- 6.10.1 Caribou Company Information
- 6.10.2 Caribou Business Overview
- 6.10.3 Caribou CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Caribou CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.10.5 Caribou Recent Developments
- 6.11 Horizon Discovery Ltd.
- 6.11.1 Horizon Discovery Ltd. Company Information
- 6.11.2 Horizon Discovery Ltd. Business Overview
- 6.11.3 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.11.5 Horizon Discovery Ltd. Recent Developments
- 6.12 EdiGene, Inc.
- 6.12.1 EdiGene, Inc. Company Information
- 6.12.2 EdiGene, Inc. Business Overview
- 6.12.3 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.12.5 EdiGene, Inc. Recent Developments
- 6.13 DetaiBio
- 6.13.1 DetaiBio Company Information
- 6.13.2 DetaiBio Business Overview
- 6.13.3 DetaiBio CRISPR-Cas9 Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 DetaiBio CRISPR-Cas9 Gene Editing Service Product Portfolio
- 6.13.5 DetaiBio Recent Developments
7 North America
- 7.1 North America CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 7.2 North America CRISPR-Cas9 Gene Editing Service Market Size by Type
- 7.2.1 North America CRISPR-Cas9 Gene Editing Service Market Size by Type (2021-2026)
- 7.2.2 North America CRISPR-Cas9 Gene Editing Service Market Size by Type (2027-2032)
- 7.2.3 North America CRISPR-Cas9 Gene Editing Service Market Share by Type (2021-2032)
- 7.3 North America CRISPR-Cas9 Gene Editing Service Market Size by Application
- 7.3.1 North America CRISPR-Cas9 Gene Editing Service Market Size by Application (2021-2026)
- 7.3.2 North America CRISPR-Cas9 Gene Editing Service Market Size by Application (2027-2032)
- 7.3.3 North America CRISPR-Cas9 Gene Editing Service Market Share by Application (2021-2032)
- 7.4 North America CRISPR-Cas9 Gene Editing Service Market Size by Country
- 7.4.1 North America CRISPR-Cas9 Gene Editing Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 7.4.3 North America CRISPR-Cas9 Gene Editing Service Market Size by Country (2027-2032)
- 7.4.4 North America CRISPR-Cas9 Gene Editing Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 8.2 Europe CRISPR-Cas9 Gene Editing Service Market Size by Type
- 8.2.1 Europe CRISPR-Cas9 Gene Editing Service Market Size by Type (2021-2026)
- 8.2.2 Europe CRISPR-Cas9 Gene Editing Service Market Size by Type (2027-2032)
- 8.2.3 Europe CRISPR-Cas9 Gene Editing Service Market Share by Type (2021-2032)
- 8.3 Europe CRISPR-Cas9 Gene Editing Service Market Size by Application
- 8.3.1 Europe CRISPR-Cas9 Gene Editing Service Market Size by Application (2021-2026)
- 8.3.2 Europe CRISPR-Cas9 Gene Editing Service Market Size by Application (2027-2032)
- 8.3.3 Europe CRISPR-Cas9 Gene Editing Service Market Share by Application (2021-2032)
- 8.4 Europe CRISPR-Cas9 Gene Editing Service Market Size by Country
- 8.4.1 Europe CRISPR-Cas9 Gene Editing Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 8.4.3 Europe CRISPR-Cas9 Gene Editing Service Market Size by Country (2027-2032)
- 8.4.4 Europe CRISPR-Cas9 Gene Editing Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 9.2 China CRISPR-Cas9 Gene Editing Service Market Size by Type
- 9.2.1 China CRISPR-Cas9 Gene Editing Service Market Size by Type (2021-2026)
- 9.2.2 China CRISPR-Cas9 Gene Editing Service Market Size by Type (2027-2032)
- 9.2.3 China CRISPR-Cas9 Gene Editing Service Market Share by Type (2021-2032)
- 9.3 China CRISPR-Cas9 Gene Editing Service Market Size by Application
- 9.3.1 China CRISPR-Cas9 Gene Editing Service Market Size by Application (2021-2026)
- 9.3.2 China CRISPR-Cas9 Gene Editing Service Market Size by Application (2027-2032)
- 9.3.3 China CRISPR-Cas9 Gene Editing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 10.2 Asia CRISPR-Cas9 Gene Editing Service Market Size by Type
- 10.2.1 Asia CRISPR-Cas9 Gene Editing Service Market Size by Type (2021-2026)
- 10.2.2 Asia CRISPR-Cas9 Gene Editing Service Market Size by Type (2027-2032)
- 10.2.3 Asia CRISPR-Cas9 Gene Editing Service Market Share by Type (2021-2032)
- 10.3 Asia CRISPR-Cas9 Gene Editing Service Market Size by Application
- 10.3.1 Asia CRISPR-Cas9 Gene Editing Service Market Size by Application (2021-2026)
- 10.3.2 Asia CRISPR-Cas9 Gene Editing Service Market Size by Application (2027-2032)
- 10.3.3 Asia CRISPR-Cas9 Gene Editing Service Market Share by Application (2021-2032)
- 10.4 Asia CRISPR-Cas9 Gene Editing Service Market Size by Country
- 10.4.1 Asia CRISPR-Cas9 Gene Editing Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 10.4.3 Asia CRISPR-Cas9 Gene Editing Service Market Size by Country (2027-2032)
- 10.4.4 Asia CRISPR-Cas9 Gene Editing Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Type
- 11.2.1 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Application
- 11.3.1 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Country
- 11.4.1 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst